nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000801	0.000801	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000801	0.000801	CcSEcCtD
Brinzolamide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000801	0.000801	CcSEcCtD
Brinzolamide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000801	0.000801	CcSEcCtD
Brinzolamide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000801	0.000801	CcSEcCtD
Brinzolamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.0008	0.0008	CcSEcCtD
Brinzolamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000798	0.000798	CcSEcCtD
Brinzolamide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000797	0.000797	CcSEcCtD
Brinzolamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000796	0.000796	CcSEcCtD
Brinzolamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000796	0.000796	CcSEcCtD
Brinzolamide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000796	0.000796	CcSEcCtD
Brinzolamide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000794	0.000794	CcSEcCtD
Brinzolamide—Pain—Vincristine—peripheral nervous system neoplasm	0.000794	0.000794	CcSEcCtD
Brinzolamide—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000794	0.000794	CcSEcCtD
Brinzolamide—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000794	0.000794	CcSEcCtD
Brinzolamide—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000792	0.000792	CcSEcCtD
Brinzolamide—Rash—Melphalan—peripheral nervous system neoplasm	0.000791	0.000791	CcSEcCtD
Brinzolamide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00079	0.00079	CcSEcCtD
Brinzolamide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000784	0.000784	CcSEcCtD
Brinzolamide—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000783	0.000783	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000779	0.000779	CcSEcCtD
Brinzolamide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000775	0.000775	CcSEcCtD
Brinzolamide—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000775	0.000775	CcSEcCtD
Brinzolamide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000767	0.000767	CcSEcCtD
Brinzolamide—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000767	0.000767	CcSEcCtD
Brinzolamide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Brinzolamide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Brinzolamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000761	0.000761	CcSEcCtD
Brinzolamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000755	0.000755	CcSEcCtD
Brinzolamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000755	0.000755	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000748	0.000748	CcSEcCtD
Brinzolamide—Infection—Etoposide—peripheral nervous system neoplasm	0.000747	0.000747	CcSEcCtD
Brinzolamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000745	0.000745	CcSEcCtD
Brinzolamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000745	0.000745	CcSEcCtD
Brinzolamide—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000741	0.000741	CcSEcCtD
Brinzolamide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000737	0.000737	CcSEcCtD
Brinzolamide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000734	0.000734	CcSEcCtD
Brinzolamide—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000733	0.000733	CcSEcCtD
Brinzolamide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000732	0.000732	CcSEcCtD
Brinzolamide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00073	0.00073	CcSEcCtD
Brinzolamide—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000725	0.000725	CcSEcCtD
Brinzolamide—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000722	0.000722	CcSEcCtD
Brinzolamide—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000717	0.000717	CcSEcCtD
Brinzolamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000714	0.000714	CcSEcCtD
Brinzolamide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000713	0.000713	CcSEcCtD
Brinzolamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000711	0.000711	CcSEcCtD
Brinzolamide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00071	0.00071	CcSEcCtD
Brinzolamide—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.00071	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000709	0.000709	CcSEcCtD
Brinzolamide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000703	0.000703	CcSEcCtD
Brinzolamide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000702	0.000702	CcSEcCtD
Brinzolamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000691	0.000691	CcSEcCtD
Brinzolamide—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000686	0.000686	CcSEcCtD
Brinzolamide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000685	0.000685	CcSEcCtD
Brinzolamide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000684	0.000684	CcSEcCtD
Brinzolamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000682	0.000682	CcSEcCtD
Brinzolamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000676	0.000676	CcSEcCtD
Brinzolamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000675	0.000675	CcSEcCtD
Brinzolamide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00067	0.00067	CcSEcCtD
Brinzolamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000669	0.000669	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000668	0.000668	CcSEcCtD
Brinzolamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000666	0.000666	CcSEcCtD
Brinzolamide—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000661	0.000661	CcSEcCtD
Brinzolamide—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000661	0.000661	CcSEcCtD
Brinzolamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000661	0.000661	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00066	0.00066	CcSEcCtD
Brinzolamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000659	0.000659	CcSEcCtD
Brinzolamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000655	0.000655	CcSEcCtD
Brinzolamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000654	0.000654	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000649	0.000649	CcSEcCtD
Brinzolamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000648	0.000648	CcSEcCtD
Brinzolamide—Pain—Etoposide—peripheral nervous system neoplasm	0.000643	0.000643	CcSEcCtD
Brinzolamide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000642	0.000642	CcSEcCtD
Brinzolamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000637	0.000637	CcSEcCtD
Brinzolamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000635	0.000635	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000634	0.000634	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000625	0.000625	CcSEcCtD
Brinzolamide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000623	0.000623	CcSEcCtD
Brinzolamide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00062	0.00062	CcSEcCtD
Brinzolamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00062	0.00062	CcSEcCtD
Brinzolamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000617	0.000617	CcSEcCtD
Brinzolamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000614	0.000614	CcSEcCtD
Brinzolamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000613	0.000613	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000612	0.000612	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000612	0.000612	CcSEcCtD
Brinzolamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.000607	CcSEcCtD
Brinzolamide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.000607	CcSEcCtD
Brinzolamide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000605	0.000605	CcSEcCtD
Brinzolamide—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000604	0.000604	CcSEcCtD
Brinzolamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000604	0.000604	CcSEcCtD
Brinzolamide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000597	0.000597	CcSEcCtD
Brinzolamide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000595	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000594	CcSEcCtD
Brinzolamide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Brinzolamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Brinzolamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000589	0.000589	CcSEcCtD
Brinzolamide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000589	0.000589	CcSEcCtD
Brinzolamide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000586	0.000586	CcSEcCtD
Brinzolamide—Rash—Vincristine—peripheral nervous system neoplasm	0.000585	0.000585	CcSEcCtD
Brinzolamide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000585	0.000585	CcSEcCtD
Brinzolamide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000584	CcSEcCtD
Brinzolamide—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000583	0.000583	CcSEcCtD
Brinzolamide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000582	0.000582	CcSEcCtD
Brinzolamide—Headache—Vincristine—peripheral nervous system neoplasm	0.000582	0.000582	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000578	0.000578	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.000574	CcSEcCtD
Brinzolamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Brinzolamide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Brinzolamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000562	0.000562	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.000559	CcSEcCtD
Brinzolamide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Brinzolamide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Brinzolamide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000553	0.000553	CcSEcCtD
Brinzolamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000551	0.000551	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000551	0.000551	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.000541	CcSEcCtD
Brinzolamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000538	0.000538	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000538	0.000538	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000535	CcSEcCtD
Brinzolamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00053	0.00053	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Brinzolamide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000524	CcSEcCtD
Brinzolamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Brinzolamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000518	0.000518	CcSEcCtD
Brinzolamide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000517	0.000517	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Brinzolamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000515	0.000515	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.000513	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000512	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000509	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000509	0.000509	CcSEcCtD
Brinzolamide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.0005	0.0005	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000498	CcSEcCtD
Brinzolamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000497	0.000497	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000497	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000495	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.00049	CcSEcCtD
Brinzolamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000487	0.000487	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000485	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.000481	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000479	CcSEcCtD
Brinzolamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Brinzolamide—Rash—Etoposide—peripheral nervous system neoplasm	0.000474	0.000474	CcSEcCtD
Brinzolamide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000474	0.000474	CcSEcCtD
Brinzolamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000471	0.000471	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.000471	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.000469	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000468	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000459	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000456	CcSEcCtD
Brinzolamide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000451	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00045	0.00045	CcSEcCtD
Brinzolamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000447	0.000447	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000446	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000443	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00044	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000439	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000437	CcSEcCtD
Brinzolamide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000431	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000429	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Brinzolamide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Brinzolamide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.000402	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.000398	CcSEcCtD
Brinzolamide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000394	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000387	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000384	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Brinzolamide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000375	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000366	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Brinzolamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000363	CcSEcCtD
Brinzolamide—Pain—Epirubicin—peripheral nervous system neoplasm	0.00036	0.00036	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000355	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000348	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000347	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000347	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000337	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000335	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000334	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000321	CcSEcCtD
Brinzolamide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00031	CcSEcCtD
Brinzolamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000302	CcSEcCtD
Brinzolamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Brinzolamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Brinzolamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000279	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Brinzolamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000268	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000267	CcSEcCtD
Brinzolamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Brinzolamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000264	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000258	CcSEcCtD
Brinzolamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00025	0.00025	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000246	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000246	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000244	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000232	CcSEcCtD
